Charming Shoppes Inc. | TalkMarkets

Latest Posts

Week In Review: Tang Capital Offers $465 Million For LianBio Plus 80% Of Any Licenses/Divestments

Article By: ChinaBio® Today

Saturday, December 2, 2023 1:20 PM EDT

LianBio received a $465 million buyout offer from Tang Capital Management. In addition, Tang also offered shareholders a contingent value right for 80% of net proceeds from any license or divestment of a LianBio holding.

In this article: AZN, CHRS, GRCL, LIAN Also: MRK, IVBXF

Read

Week In Review: Hengrui Out-Licenses Next-Gen PARP1 To Merck KGaA For $1.7 Billion

Article By: ChinaBio® Today

Saturday, November 4, 2023 3:00 PM EDT

Jiangsu Hengrui Pharma out-licensed global rights for its next-gen PARP1 inhibitor to Germany’s Merck KGaA for a $170 million upfront payment and up to $1.5 billion in milestones. Merck will have rights to manufacture and commercialize the drug.

In this article: MKGAF, BLRX, CHRS, IVBXF, SHJBF Also: LLY

Read

Biotech Alert: Searches Spiking For These Stocks Today - Friday, June 2

Article By: The Fly

Friday, June 2, 2023 4:30 PM EDT

Various names in the biotech sector are seeing a substantial increase in search activity today. Such names include the likes of Akebia Therapeautics, Corvus Pharmaceuticals, and Mirati Therapeutics.

In this article: CHRS, AKBA, CRVS, IOVA, MRTX

Read

4 Biotech Stocks That Could Keep Beating Wall Street

Article By: Zacks Investment Research

Monday, November 11, 2019 1:41 PM EDT

The size of the biotechnology market was valued at $399.4 billion in 2017 and is expected to witness a compound annual growth rate of 9.9% during the forecast period 2018-2024. Here are four stock choises.